{"DataElement":{"publicId":"14483678","version":"1","preferredName":"Person Comorbidity Type","preferredDefinition":"The class or category of the secondary disease(s).","longName":"comorbidity","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"14483676","version":"1","preferredName":"Person Comorbidity","preferredDefinition":"A human being.:The coexistence of two or more disease processes.","longName":"2236731v1.00:2829778v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2829778","version":"1","preferredName":"Comorbidity","preferredDefinition":"The coexistence of two or more disease processes.","longName":"C16457","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"616AAE12-2597-09E1-E040-BB89AD43623A","latestVersionIndicator":"Yes","beginDate":"2009-01-26","endDate":null,"createdBy":"CZECHS","dateCreated":"2009-01-26","modifiedBy":"ONEDATA","dateModified":"2009-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"05BC5A17-69C9-4F84-E063-731AD00AB96B","latestVersionIndicator":"Yes","beginDate":"2023-09-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-09-19","modifiedBy":"COLBERTM","dateModified":"2023-10-17","changeDescription":null,"administrativeNotes":"10/17/23 Edited OC and property. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14483677","version":"1","preferredName":"Comorbidity Type","preferredDefinition":"The coexistence of two or more disease processes._Something distinguishable as an identifiable class based on common qualities.","longName":"14483677v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Acute Renal Failure","valueDescription":null,"ValueMeaning":{"publicId":"2943963","version":"1","preferredName":"Acute renal failure","longName":"2943963","preferredDefinition":"Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Renal Failure","conceptCode":"C26808","definition":"Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742CB3BE-B95F-F51E-E040-BB89AD432000","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"MAESKEB","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E69EC-4D2E-58DC-E063-731AD00A59E6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2831117","version":"1","preferredName":"Adenocarcinoma","longName":"2831117","preferredDefinition":"carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D06-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F0E-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Adrenocortical Insufficiency","valueDescription":null,"ValueMeaning":{"publicId":"5621717","version":"1","preferredName":"Adrenocortical Insufficiency","longName":"5621717","preferredDefinition":"An endocrine or hormonal disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex (Addison's disease or primary adrenal insufficiency) or to inadequate secretion of ACTH by the pituitary gland (secondary adrenal insufficiency).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenocortical Insufficiency","conceptCode":"C26691","definition":"An endocrine or hormonal disorder that occurs when the adrenal cortex does not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal cortex (Addison's disease or primary adrenal insufficiency) or to inadequate secretion of ACTH by the pituitary gland (secondary adrenal insufficiency).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-ED18-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"GDEEN","dateModified":"2023-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F0F-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Alpha-1 Antitrypsin","valueDescription":null,"ValueMeaning":{"publicId":"14527986","version":"1","preferredName":"Alpha-1-Antitrypsin","longName":"14527986v1.00","preferredDefinition":"Alpha-1-antitrypsin (418 aa, ~47 kDa) is encoded by the human SERPINA1 gene. This protein plays a role in regulation of proteolysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alpha-1-Antitrypsin","conceptCode":"C105012","definition":"Alpha-1-antitrypsin (418 aa, ~47 kDa) is encoded by the human SERPINA1 gene. This protein plays a role in regulation of proteolysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"074E7195-3F0D-5A0C-E063-731AD00AA6EE","latestVersionIndicator":"Yes","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F10-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Anemia","valueDescription":null,"ValueMeaning":{"publicId":"4291759","version":"1","preferredName":"Anemia","longName":"4291759","preferredDefinition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6419-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F11-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Anxiety","valueDescription":null,"ValueMeaning":{"publicId":"2746213","version":"1","preferredName":"Anxiety","longName":"2746213","preferredDefinition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anxiety","conceptCode":"C26696","definition":"Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FCBB-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F12-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Arrhythmia","valueDescription":null,"ValueMeaning":{"publicId":"4733351","version":"1","preferredName":"Arrhythmia","longName":"4733351","preferredDefinition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A38B-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F13-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Arthritis","valueDescription":null,"ValueMeaning":{"publicId":"3292693","version":"1","preferredName":"Arthritis","longName":"3292693","preferredDefinition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthritis","conceptCode":"C2883","definition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D99F-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F14-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Asthma","valueDescription":null,"ValueMeaning":{"publicId":"2975594","version":"1","preferredName":"Asthma","longName":"2975594","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B206-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F15-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Atrial Fibrillation","valueDescription":null,"ValueMeaning":{"publicId":"2760267","version":"1","preferredName":"Atrial Fibrillation","longName":"2760267","preferredDefinition":"A supraventricular arrhythmia characterized by uncoordinated atrial myocardium activation due to multiple reentry circuits with consequent deterioration of atrial mechanical function. Instead of intermittently contracting, the atria quiver continuously in a chaotic pattern, causing a totally irregular, often tachycardia ventricular rate. On the ECG it is described by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape, and timing, associated with an irregular, frequently rapid ventricular response when atrioventricular conduction is intact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atrial Fibrillation","conceptCode":"C50466","definition":"A disorder characterized by an electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregular ventricular response. (CDISC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3C42-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F16-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Avascular Necrosis","valueDescription":null,"ValueMeaning":{"publicId":"4733331","version":"1","preferredName":"Avascular Necrosis","longName":"4733331","preferredDefinition":"Tissue death resulting from an interruption to the blood supply.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Avascular Necrosis","conceptCode":"C118385","definition":"Tissue death resulting from an interruption to the blood supply.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107C4D77-22B7-10F2-E050-BB89AD437429","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F17-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Basal Cell Carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"6796707","version":"1","preferredName":"Basal Cell Carcinoma","longName":"6796707","preferredDefinition":"A carcinoma involving the basal cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basal Cell Carcinoma","conceptCode":"C156767","definition":"A carcinoma involving the basal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C5201B3-6FFD-5291-E053-F662850A82DE","latestVersionIndicator":"Yes","beginDate":"2019-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-27","modifiedBy":"ONEDATA","dateModified":"2019-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F18-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Blood Clots","valueDescription":null,"ValueMeaning":{"publicId":"2757885","version":"1","preferredName":"Blood Clot","longName":"2757885","preferredDefinition":"An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood Clot","conceptCode":"C27083","definition":"An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D608-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E7195-3F19-5A0C-E063-731AD00AA6EE","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Depression","valueDescription":null,"ValueMeaning":{"publicId":"2746223","version":"1","preferredName":"Depression","longName":"2746223","preferredDefinition":"Depression; a mental state of depressed mood characterised by feelings of sadness, despair and discouragement. (On-line Medical Dictionary)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Depression","conceptCode":"C2982","definition":"A melancholy feeling of sadness and despair.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C16B073-3A2F-3FCC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074E9A0A-84C5-60A9-E063-731AD00AF36C","beginDate":"2023-10-09","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-10-09","modifiedBy":"CLOHNES","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Bronchitis","valueDescription":null,"ValueMeaning":{"publicId":"2944459","version":"1","preferredName":"Bronchitis","longName":"2944459","preferredDefinition":"An acute or chronic inflammatory process affecting the bronchi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchitis","conceptCode":"C2911","definition":"An acute or chronic inflammatory process affecting the bronchi.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74331C4B-D5AB-D41C-E040-BB89AD435AA5","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D00A-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Celiac Disease","valueDescription":null,"ValueMeaning":{"publicId":"3249580","version":"1","preferredName":"Celiac Disease","longName":"3249580","preferredDefinition":"A digestive disease that is caused by an immune response to a protein called gluten, which is found in wheat, rye, barley, and oats. Celiac disease damages the lining of the small intestine and interferes with the absorption of nutrients from food. A person with celiac disease may become malnourished no matter how much food is consumed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Celiac Disease","conceptCode":"C26714","definition":"An autoimmune genetic disorder with an unknown pattern of inheritance that primarily affects the digestive tract. It is caused by intolerance to dietary gluten. Consumption of gluten protein triggers an immune response which damages small intestinal villi and prevents adequate absorption of nutrients. Clinical signs include abdominal cramping, diarrhea or constipation and weight loss. If untreated, the clinical course may progress to malnutrition, anemia, osteoporosis and an increased risk of intestinal malignancies. However, the prognosis is favorable with successful avoidance of gluten in the diet.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D99025-BE2B-DBB4-E040-BB89AD434418","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D00B-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Cholelithiasis","valueDescription":null,"ValueMeaning":{"publicId":"6514326","version":"1","preferredName":"Cholelithiasis","longName":"6514326","preferredDefinition":"The presence of calculi in the gallbladder.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholelithiasis","conceptCode":"C122822","definition":"The presence of calculi in the gallbladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB15-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"ONEDATA","dateModified":"2018-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D00C-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Chronic Renal Failure","valueDescription":null,"ValueMeaning":{"publicId":"3210781","version":"1","preferredName":"Chronic Renal Failure","longName":"3210781","preferredDefinition":"Impairment of the renal function due to chronic kidney damage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Renal Failure","conceptCode":"C9438","definition":"Impairment of the renal function due to chronic kidney damage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9E9C-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D00D-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Common Variable Immunodeficiency","valueDescription":null,"ValueMeaning":{"publicId":"2579841","version":"1","preferredName":"Common Variable Immunodeficiency","longName":"2579841","preferredDefinition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Variable Immunodeficiency","conceptCode":"C26725","definition":"A primary immunodeficiency characterized by low levels or absence of all the immunoglobulin classes and lack of B-lymphocytes or plasma cells. It results in recurrent bacterial infections. Complications include autoimmune phenomena and cancer development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04EE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition to use current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D00E-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Connective Tissue Disorder","valueDescription":null,"ValueMeaning":{"publicId":"4395743","version":"1","preferredName":"Connective Tissue Disorder","longName":"4395743","preferredDefinition":"A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Connective Tissue Disorder","conceptCode":"C26729","definition":"A non-neoplastic or neoplastic disorder that affects the connective tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D581-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D00F-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Coronary Artery Disease","valueDescription":null,"ValueMeaning":{"publicId":"2760269","version":"1","preferredName":"Coronary Disease","longName":"2760269","preferredDefinition":"An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary Artery Disease","conceptCode":"C26732","definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3CA7-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D010-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Cryptogenic Organizing Pneumonia","valueDescription":null,"ValueMeaning":{"publicId":"5021901","version":"1","preferredName":"Cryptogenic Organizing Pneumonia","longName":"5021901","preferredDefinition":"A disease formerly considered a form of interstitial pneumonia. Its etiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. \"Organizing\" refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryptogenic Organizing Pneumonia","conceptCode":"C62586","definition":"A form of organizing pneumonia with a non-infectious etiology. Excessive proliferation of granulation tissue occurs in alveolar ducts and alveoli and primarily causes injury to alveolar walls, but bronchioles may be affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2047C974-496A-BBB9-E050-BB89AD4355F1","latestVersionIndicator":"Yes","beginDate":"2015-09-21","endDate":null,"createdBy":"SORENSENS","dateCreated":"2015-09-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D011-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Denys-Drash Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211013","version":"1","preferredName":"Denys-Drash Syndrome","longName":"3211013","preferredDefinition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Denys-Drash Syndrome","conceptCode":"C84668","definition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C17E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECA18-D012-6A5E-E063-731AD00A50B6","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Diabetic Neuropathy","valueDescription":null,"ValueMeaning":{"publicId":"5040588","version":"1","preferredName":"Diabetic Neuropathy","longName":"5040588","preferredDefinition":"Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetic Neuropathy","conceptCode":"C26748","definition":"A chronic, pathological complication associated with diabetes mellitus, where nerve damages are incurred due to diabetic microvascular injury involving small blood vessels that supply these nerves, resulting in peripheral and/or autonomic nerve dysfunction.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"235310F3-A300-CA55-E050-BB89AD432272","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-10-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECCB6-3607-6AF8-E063-731AD00A4AEB","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Diverticulitis","valueDescription":null,"ValueMeaning":{"publicId":"2577629","version":"1","preferredName":"Diverticulitis","longName":"2577629","preferredDefinition":"An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diverticulitis","conceptCode":"C26752","definition":"An infection that develops in the diverticula of the intestinal tract. Signs and symptoms include abdominal pain, fever, and leukocytosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FC4A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-02-08","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition with current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECCB6-3608-6AF8-E063-731AD00A4AEB","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Dyslipidemia","valueDescription":null,"ValueMeaning":{"publicId":"14527987","version":"1","preferredName":"Dyslipidemia","longName":"14527987v1.00","preferredDefinition":"A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyslipidemia","conceptCode":"C80385","definition":"A lipoprotein metabolism disorder characterized by decreased levels of high-density lipoproteins, or elevated levels of plasma cholesterol, low-density lipoproteins and/or triglycerides.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"074ECCB6-3606-6AF8-E063-731AD00A4AEB","latestVersionIndicator":"Yes","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECCB6-3609-6AF8-E063-731AD00A4AEB","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Eczema","valueDescription":null,"ValueMeaning":{"publicId":"3252129","version":"1","preferredName":"Eczema","longName":"3252129","preferredDefinition":"A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eczema","conceptCode":"C3001","definition":"A form of dermatitis characterized by red, itchy, scaly, or crusty patches that can be chronic or intermittent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A781D14A-E852-8A44-E040-BB89AD4310FD","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.20 Updated definition with current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ECCB6-360A-6AF8-E063-731AD00A4AEB","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Epstein-Barr Virus","valueDescription":null,"ValueMeaning":{"publicId":"5527882","version":"1","preferredName":"Epstein-Barr Virus","longName":"5527882","preferredDefinition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epstein-Barr Virus","conceptCode":"C14204","definition":"A species of Herpetoviridae that is responsible for infectious mononucleosis (glandular fever). Discovered in 1964, this virus has been associated with Burkitt's lymphoma in South African children and with nasopharyngeal carcinoma in Asian populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3F4C6595-C88A-7E5D-E053-F662850A57F1","latestVersionIndicator":"Yes","beginDate":"2016-10-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-10-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-2338-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Familial Adenomatous Polyposis","valueDescription":null,"ValueMeaning":{"publicId":"2577526","version":"1","preferredName":"Adenomatous Polyposis Coli","longName":"2577526","preferredDefinition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Familial Adenomatous Polyposis","conceptCode":"C3339","definition":"An autosomal dominant disorder, characterized by the presence of multiple adenomas in the colon and rectum. It is caused by a germline mutation in the adenomatous polyposis coli (APC) gene which is located on the long arm of chromosome 5. The adenomas are most often tubular, and they have the tendency to progress to adenocarcinoma. They can occur throughout the colon, but they tend to concentrate in the rectum and sigmoid colon. The colorectal adenomas are detected during endoscopic examination between the age of 10 and 20 years. The adenomas increase in size and numbers with age, and there is usually progression of one or more adenomas to adenocarcinoma. The mean age of development of adenocarcinoma is about 40 years. Signs include rectal bleeding and mucousy diarrhea.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FBE3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-01-28","modifiedBy":"COOPERM","dateModified":"2018-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-2339-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Fanconi Anemia","valueDescription":null,"ValueMeaning":{"publicId":"5651022","version":"1","preferredName":"Fanconi Anemia","longName":"5651022","preferredDefinition":"A rare inherited disorder in which the bone marrow does not make blood cells. It is usually diagnosed in children between 2 and 15 years old. Symptoms include frequent infections, easy bleeding, and extreme tiredness. People with Fanconi anemia may have a small skeleton and brown spots on the skin. They also have an increased risk of developing certain types of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fanconi Anemia","conceptCode":"C62505","definition":"An autosomal recessive genetic disorder characterized by bone marrow failure, skeletal abnormalities, and an increased incidence of the development of neoplasias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"479020AD-0CB9-3909-E053-F662850A62CA","latestVersionIndicator":"Yes","beginDate":"2017-02-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-02-02","modifiedBy":"KUMMEROA","dateModified":"2023-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-233A-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Fibrosis","valueDescription":null,"ValueMeaning":{"publicId":"4264818","version":"1","preferredName":"Fibrosis","longName":"4264818","preferredDefinition":"The formation of fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FCDE-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.2020 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-233B-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Gastroesophageal Reflux Disease","valueDescription":null,"ValueMeaning":{"publicId":"2944845","version":"1","preferredName":"Gastroesophageal Reflux Disease","longName":"2944845","preferredDefinition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroesophageal Reflux Disease","conceptCode":"C26781","definition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74450F48-355A-F0DB-E040-BB89AD437C48","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-233C-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Glaucoma","valueDescription":null,"ValueMeaning":{"publicId":"4395747","version":"1","preferredName":"Glaucoma","longName":"4395747","preferredDefinition":"Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glaucoma","conceptCode":"C26782","definition":"Increased pressure in the eyeball due to obstruction of the outflow of aqueous humor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D60D-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-233D-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Glycogen Storage Disease","valueDescription":null,"ValueMeaning":{"publicId":"2593481","version":"1","preferredName":"Glycogen Storage Disease","longName":"2593481","preferredDefinition":"An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glycogen Storage Disease","conceptCode":"C61272","definition":"An inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28BD3AD6-BCD6-64E1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-233E-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Gout","valueDescription":null,"ValueMeaning":{"publicId":"2746390","version":"1","preferredName":"Gout","longName":"2746390","preferredDefinition":"Hereditary metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of uric acid calculi.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gout","conceptCode":"C34650","definition":"A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C20DB99-7334-0BA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-233F-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Headache","valueDescription":null,"ValueMeaning":{"publicId":"2719266","version":"1","preferredName":"Headache","longName":"2719266","preferredDefinition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Headache","conceptCode":"C34661","definition":"Pain in various parts of the head, not confined to the area of distribution of any nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4351B20D-E735-1D1B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALAIS","dateCreated":"2008-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-2340-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hemihypertrophy","valueDescription":null,"ValueMeaning":{"publicId":"3078440","version":"1","preferredName":"Hemihypertrophy","longName":"3078440","preferredDefinition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemihypertrophy","conceptCode":"C88541","definition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85399A6D-D1E3-B88C-E040-BB89AD431518","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED287-2341-6BA1-E063-731AD00AB73C","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hemorrhagic Cystitis","valueDescription":null,"ValueMeaning":{"publicId":"5621720","version":"1","preferredName":"Hemorrhagic Cystitis","longName":"5621720","preferredDefinition":"Inflammation of the bladder resulting in bloody urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhagic Cystitis","conceptCode":"C114666","definition":"Inflammation of the bladder resulting in bloody urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-EDB2-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCCF-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hepatitis","valueDescription":null,"ValueMeaning":{"publicId":"3257061","version":"1","preferredName":"Hepatitis","longName":"3257061","preferredDefinition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8AA35B8-AD6E-E3A8-E040-BB89AD43122A","latestVersionIndicator":"Yes","beginDate":"2011-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD0-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hepatitis A Infection","valueDescription":null,"ValueMeaning":{"publicId":"2567486","version":"1","preferredName":"Hepatitis A","longName":"2567486","preferredDefinition":"Hepatitis caused by HEPATOVIRUS. It can be transmitted through fecal contamination of food or water.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis A Infection","conceptCode":"C3096","definition":"Acute inflammation of the liver caused by the hepatitis A virus. It is highly contagious and usually contracted through close contact with an infected individual or their feces, contaminated food or water.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4AB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD1-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hepatitis B Infection","valueDescription":null,"ValueMeaning":{"publicId":"4761116","version":"1","preferredName":"Hepatitis B Infection","longName":"4761116v1.00","preferredDefinition":"A viral infection caused by the hepatitis B virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Infection","conceptCode":"C3097","definition":"A viral infection caused by the hepatitis B virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12375748-2AE9-8D8D-E050-BB89AD430CF5","latestVersionIndicator":"Yes","beginDate":"2015-03-26","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-03-26","modifiedBy":"GDEEN","dateModified":"2023-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD2-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hepatitis C Infection","valueDescription":null,"ValueMeaning":{"publicId":"2975596","version":"1","preferredName":"Hepatitis C","longName":"2975596","preferredDefinition":"An RNA virus, causes non-A and non-B Hepatitis and liver cancer","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Infection","conceptCode":"C3098","definition":"A viral infection caused by the hepatitis C virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0F01-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD3-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"High Grade Liver Dysplastic Nodule","valueDescription":null,"ValueMeaning":{"publicId":"6423727","version":"1","preferredName":"High Grade Liver Dysplastic Nodule","longName":"6423727","preferredDefinition":"A hepatic dysplastic nodule characterized by the presence of high grade atypical cellular changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Liver Dysplastic Nodule","conceptCode":"C96768","definition":"A hepatic dysplastic nodule characterized by the presence of high grade atypical cellular changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-883B-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD4-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Human Papillomavirus Infection","valueDescription":null,"ValueMeaning":{"publicId":"7469670","version":"1","preferredName":"Human Papillomavirus Infection","longName":"7469670","preferredDefinition":"An infectious process caused by a human papillomavirus. This infection can cause abnormal tissue growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Papillomavirus Infection","conceptCode":"C27851","definition":"An infectious process caused by a human papillomavirus. This infection can cause abnormal tissue growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6E36-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD5-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hypercholesterolemia","valueDescription":null,"ValueMeaning":{"publicId":"2751387","version":"1","preferredName":"Hypercholesterolemia","longName":"2751387","preferredDefinition":"Hypercholesterolemia; the presence of an abnormal amount of cholesterol in the cells and plasma of the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypercholesterolemia","conceptCode":"C37967","definition":"A laboratory test result indicating an increased amount of cholesterol in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-08A4-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD6-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hypercalcemia","valueDescription":null,"ValueMeaning":{"publicId":"2946170","version":"1","preferredName":"Hypercalcemia","longName":"2946170","preferredDefinition":"Abnormally high concentration of calcium in the peripheral blood. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypercalcemia","conceptCode":"C3112","definition":"Abnormally high concentration of calcium in the peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-499A-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD7-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hyperglycemia","valueDescription":null,"ValueMeaning":{"publicId":"4395749","version":"1","preferredName":"Hyperglycemia","longName":"4395749","preferredDefinition":"Abnormally high level of glucose in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperglycemia","conceptCode":"C26797","definition":"Abnormally high level of glucose in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D653-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD8-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hyperlipidemia","valueDescription":null,"ValueMeaning":{"publicId":"2751390","version":"1","preferredName":"Hyperlipidemia","longName":"2751390","preferredDefinition":"An excess of lipids in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperlipidemia","conceptCode":"C34707","definition":"Elevated levels of lipids in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC907AE-0915-716C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCD9-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hypertension","valueDescription":null,"ValueMeaning":{"publicId":"2562555","version":"1","preferredName":"Hypertension","longName":"2562555","preferredDefinition":"Abnormally high blood pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypertension","conceptCode":"C3117","definition":"Blood pressure that is abnormally high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C168-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-04","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-10-04","modifiedBy":"ZHANGW","dateModified":"2008-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCDA-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hypospadias","valueDescription":null,"ValueMeaning":{"publicId":"7469669","version":"1","preferredName":"Hypospadias","longName":"7469669","preferredDefinition":"A congenital abnormality in which the external urethral orifice is on the underside of the penis. In a minority of cases it is associated with other genitourinary abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypospadias","conceptCode":"C40341","definition":"A congenital abnormality in which the external urethral orifice is on the underside of the penis. In a minority of cases it is associated with other genitourinary abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1D01C86-6E11-4369-E053-4EBD850A62AE","latestVersionIndicator":"Yes","beginDate":"2020-10-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-10-16","modifiedBy":"ONEDATA","dateModified":"2020-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCDB-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Hypothyroidism","valueDescription":null,"ValueMeaning":{"publicId":"2562672","version":"1","preferredName":"Hypothyroidism","longName":"2562672","preferredDefinition":"A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto's thyroiditis, an autoimmune disorder. SYN athyrea. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypothyroidism","conceptCode":"C26800","definition":"Abnormally low levels of thyroid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCDC-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Inflammatory Bowel Disease","valueDescription":null,"ValueMeaning":{"publicId":"5417294","version":"1","preferredName":"Inflammatory bowel disease","longName":"5417294","preferredDefinition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammatory Bowel Disease","conceptCode":"C3138","definition":"A spectrum of small and large bowel inflammatory diseases of unknown etiology. It includes Crohn's disease, ulcerative colitis, and colitis of indeterminate type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A49A30E-4268-4645-E050-BB89AD432879","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCDD-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Iron Overload","valueDescription":null,"ValueMeaning":{"publicId":"3251403","version":"1","preferredName":"Iron Storage Disease","longName":"3251403","preferredDefinition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iron Overload","conceptCode":"C78393","definition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-A4E6-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074ED6EE-BCDE-6C6B-E063-731AD00A4794","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Ischemic Heart Disease","valueDescription":null,"ValueMeaning":{"publicId":"3248585","version":"1","preferredName":"Ischemic Heart Disease","longName":"3248585","preferredDefinition":"A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries, to obstruction by a thrombus, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ischemic Heart Disease","conceptCode":"C50625","definition":"A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries, to obstruction by a thrombus, or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-C06E-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FF3-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Joint Replacement","valueDescription":null,"ValueMeaning":{"publicId":"5621715","version":"1","preferredName":"Joint replacement","longName":"5621715","preferredDefinition":"A surgical procedure to replace part, or all structures, of a joint with an orthopedic prosthesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Joint Replacement","conceptCode":"C131579","definition":"A surgical procedure to replace part, or all structures, of a joint with an orthopedic prosthesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-ECA6-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FF4-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Li-Fraumeni Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211225","version":"1","preferredName":"Li-Fraumeni Syndrome","longName":"3211225","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome caused by an alteration in the p53 tumor suppressor gene.  It is characterized by the development of malignant neoplasms at various anatomic sites.  The malignant neoplasms associated with Li-Fraumeni syndrome include adrenal cortex carcinoma, astrocytic tumors, colorectal carcinoma, gastric carcinoma, malignant breast neoplasms, medulloblastoma, osteosarcoma, and soft tissue sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Li-Fraumeni Syndrome","conceptCode":"C3476","definition":"An autosomal dominant cancer predisposition syndrome caused by germline mutations of the TP53 gene. It is associated with breast carcinoma, choroid plexus carcinoma, adrenal cortex carcinoma, astrocytic tumors, medulloblastoma, soft tissue sarcoma, osteosarcoma, and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DF6B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FF5-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Low Grade Liver Dysplastic Nodule","valueDescription":null,"ValueMeaning":{"publicId":"6423729","version":"1","preferredName":"Low Grade Liver Dysplastic Nodule","longName":"6423729","preferredDefinition":"A hepatic dysplastic nodule characterized by the presence of low grade atypical cellular changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Liver Dysplastic Nodule","conceptCode":"C96770","definition":"A hepatic dysplastic nodule characterized by the presence of low grade atypical cellular changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-8861-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FF6-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Lynch Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2716424","version":"1","preferredName":"Hereditary Non-Polyposis Colon Cancer","longName":"2716424","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma.  Patients often develop colorectal carcinomas at an early age (mean, 45 years).  In the majority of the cases the lesions arise from the proximal colon.  At the molecular level, high-frequency microsatellite instability is present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lynch Syndrome","conceptCode":"C8494","definition":"An autosomal dominant hereditary neoplastic syndrome characterized by the development of colorectal carcinoma and a high risk of developing endometrial carcinoma, gastric carcinoma, ovarian carcinoma, renal pelvis carcinoma, and small intestinal carcinoma. Patients often develop colorectal carcinomas at an early age (mean, 45 years). In the majority of the cases the lesions arise from the proximal colon. At the molecular level, high-frequency microsatellite instability is present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41B659B0-44F3-5521-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FF7-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Myasthenia Gravis","valueDescription":null,"ValueMeaning":{"publicId":"3143924","version":"1","preferredName":"Myasthenia Gravis","longName":"3143924","preferredDefinition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness.  It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myasthenia Gravis","conceptCode":"C60989","definition":"A chronic autoimmune neuromuscular disorder characterized by skeletal muscle weakness. It is caused by the blockage of the acetylcholine receptors at the neuromuscular junction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9167B9F7-3DD6-C748-E040-BB89AD432898","latestVersionIndicator":"Yes","beginDate":"2010-09-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-09-29","modifiedBy":"KUMMEROA","dateModified":"2022-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FF8-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Myocardial Infarction","valueDescription":null,"ValueMeaning":{"publicId":"2570461","version":"1","preferredName":"Myocardial Infarction","longName":"2570461","preferredDefinition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocardial Infarction","conceptCode":"C27996","definition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E04A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"MAESKEB","dateModified":"2022-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FF9-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Nonalcoholic Steatohepatitis","valueDescription":null,"ValueMeaning":{"publicId":"3210796","version":"1","preferredName":"Nonalcoholic Steatohepatitis","longName":"3210796","preferredDefinition":"Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonalcoholic Steatohepatitis","conceptCode":"C84445","definition":"Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A132-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FFA-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Obesity","valueDescription":null,"ValueMeaning":{"publicId":"2945865","version":"1","preferredName":"Obesity","longName":"2945865","preferredDefinition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Obesity","conceptCode":"C3283","definition":"Having a high amount of body fat (body mass index [BMI] of 30 or more).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-17B3-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FFB-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Osteoarthritis","valueDescription":null,"ValueMeaning":{"publicId":"3158617","version":"1","preferredName":"Osteoarthritis","longName":"3158617","preferredDefinition":"A noninflammatory degenerative joint disease occurring chiefly in older persons, characterised by degeneration of the articular cartilage, hypertrophy of bone at the margins and changes in the synovial membrane. It is accompanied by pain and stiffness, particularly after prolonged activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoarthritis","conceptCode":"C3293","definition":"A noninflammatory degenerative joint disease occurring chiefly in older persons, characterised by degeneration of the articular cartilage, hypertrophy of bone at the margins and changes in the synovial membrane. It is accompanied by pain and stiffness, particularly after prolonged activity.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94B767EB-75D2-EA97-E040-BB89AD4330C2","latestVersionIndicator":"Yes","beginDate":"2010-11-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2010-11-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FFC-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FFD-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Peptic Ulcer (Ulcer)","valueDescription":null,"ValueMeaning":{"publicId":"2573562","version":"1","preferredName":"Peptic Ulcer","longName":"2573562","preferredDefinition":"Ulcer that occurs in those portions of the alimentary tract which come into contact with gastric juice containing pepsin and acid. It occurs when the amount of acid and pepsin is sufficient to overcome the gastric mucosal barrier.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peptic Ulcer","conceptCode":"C3318","definition":"A mucosal erosion that occurs in the esophagus, stomach or duodenum. Symptoms can include abdominal pain, nausea and vomiting, and bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC67-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FFE-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Peripheral Neuropathy","valueDescription":null,"ValueMeaning":{"publicId":"7614690","version":"1","preferredName":"Peripheral Neuropathy","longName":"7614690","preferredDefinition":"A disorder affecting the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral Neuropathy","conceptCode":"C119734","definition":"A disorder affecting the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE5E8145-72E4-69B4-E053-4EBD850A24B2","latestVersionIndicator":"Yes","beginDate":"2021-03-25","endDate":null,"createdBy":"MALUMK","dateCreated":"2021-03-25","modifiedBy":"ONEDATA","dateModified":"2021-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-6FFF-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Peutz-Jeghers Disease","valueDescription":null,"ValueMeaning":{"publicId":"3211359","version":"1","preferredName":"Peutz-Jeghers Syndrome","longName":"3211359","preferredDefinition":"An inherited condition characterized by generalized hamartomatous multiple polyposis of the intestinal tract. Transmitted in an autosomal dominant fashion, Peutz-Jeghers syndrome consistently involves the jejunum and is associated with melanin spots of the lips, buccal mucosa, and fingers. This syndrome is associated with abnormalities of chromosome 19. Also known as Jeghers-Peutz syndrome and Peutz's syndrome. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peutz-Jeghers Syndrome","conceptCode":"C3324","definition":"An inherited condition characterized by generalized hamartomatous multiple polyposis of the intestinal tract. Transmitted in an autosomal dominant fashion, Peutz-Jeghers syndrome consistently involves the jejunum and is associated with melanin spots of the lips, buccal mucosa, and fingers. This syndrome is associated with abnormalities of chromosome 19. Also known as Jeghers-Peutz syndrome and Peutz's syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-F2D3-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-7000-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Primary Sclerosing Cholangitis","valueDescription":null,"ValueMeaning":{"publicId":"3210800","version":"1","preferredName":"Primary Sclerosing Cholangitis","longName":"3210800","preferredDefinition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Sclerosing Cholangitis","conceptCode":"C4828","definition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-7001-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Psoriasis","valueDescription":null,"ValueMeaning":{"publicId":"4276834","version":"1","preferredName":"Psoriasis","longName":"4276834","preferredDefinition":"An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Psoriasis","conceptCode":"C3346","definition":"An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7A209D6-78D6-98DB-E040-BB89AD4339B1","latestVersionIndicator":"Yes","beginDate":"2014-04-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2014-04-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-7002-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Pulmonary Fibrosis","valueDescription":null,"ValueMeaning":{"publicId":"2946061","version":"1","preferredName":"Pulmonary Fibrosis","longName":"2946061","preferredDefinition":"Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Fibrosis","conceptCode":"C26869","definition":"Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-64F0-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-7003-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Pulmonary Hemorrhage","valueDescription":null,"ValueMeaning":{"publicId":"5621709","version":"1","preferredName":"Pulmonary Hemorrhage","longName":"5621709","preferredDefinition":"Bleeding from the lung parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Hemorrhage","conceptCode":"C78578","definition":"Bleeding from the lung parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-EBB4-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-7004-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Rheumatoid Arthritis","valueDescription":null,"ValueMeaning":{"publicId":"2570667","version":"1","preferredName":"Rheumatoid Arthritis","longName":"2570667","preferredDefinition":"A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rheumatoid Arthritis","conceptCode":"C2884","definition":"A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E118-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CZECHS","dateModified":"2008-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EDBCF-7005-6D11-E063-731AD00A83C7","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Rubinstein-Taybi Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211427","version":"1","preferredName":"Rubinstein-Taybi Syndrome","longName":"3211427","preferredDefinition":"A rare genetic syndrome mapped to chromosome 16p13.3 and associated with mutations in the CREBBP gene.  It is characterized by mental and growth retardation, distinctive facial features (prominent nose, low-set ears, microcephaly, and small mouth), and broad thumbs and great toes.  Patients are at an increased risk of developing benign and malignant neoplasms, including nervous system neoplasms and malignant lymphoproliferative disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rubinstein-Taybi Syndrome","conceptCode":"C75466","definition":"A rare genetic syndrome mapped to chromosome 16p13.3 and associated with mutations in the CREBBP gene. It is characterized by mental and growth retardation, distinctive facial features (prominent nose, low-set ears, microcephaly, and small mouth), and broad thumbs and great toes. Patients are at an increased risk of developing benign and malignant neoplasms, including nervous system neoplasms and malignant lymphoproliferative disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FC39-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC36-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Sarcoidosis","valueDescription":null,"ValueMeaning":{"publicId":"5427584","version":"1","preferredName":"Sarcoidosis","longName":"5427584","preferredDefinition":"An idiopathic inflammatory disorder characterized by the formation of non-necrotizing epithelioid granulomas which contain giant cells. It usually affects the lungs, lymph nodes, liver, and skin. Cardiac involvement is also possible.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcoidosis","conceptCode":"C34995","definition":"An idiopathic inflammatory disorder characterized by the formation of non-necrotizing epithelioid granulomas which contain giant cells. It usually affects the lungs, lymph nodes, liver, and skin. Cardiac involvement is also possible.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E8CEE-1082-EC88-E050-BB89AD432072","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC37-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Seizure","valueDescription":null,"ValueMeaning":{"publicId":"5026016","version":"1","preferredName":"Seizure","longName":"5026016","preferredDefinition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20D2C91D-B832-E866-E050-BB89AD433C74","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC38-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Sleep apnea","valueDescription":null,"ValueMeaning":{"publicId":"2757881","version":"1","preferredName":"Sleep Apnea","longName":"2757881","preferredDefinition":"Cessation of breathing for short periods during sleep. It is classified as obstructive, central, or mixed obstructive-central. It can occur at any age but it is more frequent in people over forty. Risk factors include male sex and obesity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sleep Apnea","conceptCode":"C26884","definition":"Cessation of breathing for short periods during sleep. It is classified as obstructive, central, or mixed obstructive-central. It can occur at any age but it is more frequent in people over forty. Risk factors include male sex and obesity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D578-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC39-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Smoking","valueDescription":null,"ValueMeaning":{"publicId":"7171840","version":"1","preferredName":"Smoking","longName":"7171840","preferredDefinition":"The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Smoking","conceptCode":"C154329","definition":"The act of puffing and/or inhaling the combustion products of a substance so as to be tasted and absorbed into the bloodstream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EC99208-90BE-4F30-E053-F662850A39B0","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-02-17","modifiedBy":"ONEDATA","dateModified":"2020-02-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC3A-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Steatosis","valueDescription":null,"ValueMeaning":{"publicId":"3249618","version":"1","preferredName":"Steatosis","longName":"3249618","preferredDefinition":"A morphologic finding indicating intracytoplasmic fat accumulation in the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Steatosis","conceptCode":"C36185","definition":"Acumulation of adipose tissue in intracytoplasmic or extracellular spaces.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D9FB96-3598-EB3C-E040-BB89AD435DB4","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC3B-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Stroke","valueDescription":null,"ValueMeaning":{"publicId":"4733294","version":"1","preferredName":"Cerebrovascular Accident","longName":"4733294","preferredDefinition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A141-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC3C-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Tuberculosis","valueDescription":null,"ValueMeaning":{"publicId":"5427583","version":"1","preferredName":"Tuberculosis","longName":"5427583","preferredDefinition":"A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tuberculosis","conceptCode":"C3423","definition":"A chronic, recurrent infection caused by the bacterium Mycobacterium tuberculosis. Tuberculosis (TB) may affect almost any tissue or organ of the body with the lungs being the most common site of infection. The clinical stages of TB are primary or initial infection, latent or dormant infection, and recrudescent or adult-type TB. Ninety to 95% of primary TB infections may go unrecognized. Histopathologically, tissue lesions consist of granulomas which usually undergo central caseation necrosis. Local symptoms of TB vary according to the part affected; acute symptoms include hectic fever, sweats, and emaciation; serious complications include granulomatous erosion of pulmonary bronchi associated with hemoptysis. If untreated, progressive TB may be associated with a high degree of mortality. This infection is frequently observed in immunocompromised individuals with AIDS or a history of illicit IV drug use.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A9E8CEE-1054-EC88-E050-BB89AD432072","latestVersionIndicator":"Yes","beginDate":"2016-08-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC3D-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Turcot Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"6002212","version":"1","preferredName":"Turcot Syndrome","longName":"6002212","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome caused by mutations in the PMS2, MLH1, MSH2, or APC genes. There are two types described, type 1, characterized by the presence of glioblastoma and often associated with hereditary nonpolyposis colorectal carcinoma, and type 2, characterized by the presence of medulloblastoma and familiar adenomatous polyposis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Turcot Syndrome","conceptCode":"C3938","definition":"An autosomal dominant hereditary neoplastic syndrome caused by mutations in the PMS2, MLH1, MSH2, or APC genes. There are two types described, type 1, characterized by the presence of glioblastoma and often associated with hereditary nonpolyposis colorectal carcinoma, and type 2, characterized by the presence of medulloblastoma and familiar adenomatous polyposis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4E1CD4-4E37-160D-E053-F662850A7005","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC3E-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Tyrosinemia","valueDescription":null,"ValueMeaning":{"publicId":"6013366","version":"1","preferredName":"Tyrosinemia","longName":"6013366","preferredDefinition":"An autosomal recessive inherited metabolic disorder caused by mutations in the FAH, HPD, and TAT genes. It is characterized by deficiency of one of the enzymes that are involved in the metabolism of tyrosine. It results in elevated blood tyrosine levels and accumulation of tyrosine and its byproducts in the liver, kidney, nervous system and other organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tyrosinemia","conceptCode":"C98640","definition":"An autosomal recessive inherited metabolic disorder caused by mutations in the FAH, HPD, and TAT genes. It is characterized by deficiency of one of the enzymes that are involved in the metabolism of tyrosine. It results in elevated blood tyrosine levels and accumulation of tyrosine and its byproducts in the liver, kidney, nervous system and other organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5CD9A0AB-573B-70DD-E053-F662850A7724","latestVersionIndicator":"Yes","beginDate":"2017-10-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC3F-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Ulcerative Colitis","valueDescription":null,"ValueMeaning":{"publicId":"4264977","version":"1","preferredName":"Ulcerative Colitis","longName":"4264977","preferredDefinition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ulcerative Colitis","conceptCode":"C2952","definition":"An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3D16-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EEDD8-BC40-6F9F-E063-731AD00AA10B","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EF156-AE92-703E-E063-731AD00AEC5E","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-09","modifiedBy":"SOKKERL","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Transient Ischemic Attack","valueDescription":null,"ValueMeaning":{"publicId":"2944400","version":"1","preferredName":"Transient Ischemic Attack","longName":"2944400","preferredDefinition":"A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transient Ischemic Attack","conceptCode":"C50781","definition":"A brief attack (from a few minutes to an hour) of cerebral dysfunction of vascular origin, with no persistent neurological deficit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7431FEA7-FCE7-A5C9-E040-BB89AD4324B4","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-22","modifiedBy":"ONEDATA","dateModified":"2023-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EF156-AE93-703E-E063-731AD00AEC5E","beginDate":"2023-10-09","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-10-09","modifiedBy":"CLOHNES","dateModified":"2023-10-09","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"074EF926-DD3A-7152-E063-731AD00AAA0D","beginDate":"2023-10-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-10","modifiedBy":"SOKKERL","dateModified":"2023-10-10","deletedIndicator":"No"},{"value":"Allergic Reaction","valueDescription":null,"ValueMeaning":{"publicId":"14549068","version":"1","preferredName":"Allergic Reaction","longName":"14549068v1.00","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08258D7C-87D0-49E5-E063-731AD00AFCD1","latestVersionIndicator":"Yes","beginDate":"2023-10-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-20","modifiedBy":"KUMMEROA","dateModified":"2023-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08258D7C-87D1-49E5-E063-731AD00AFCD1","beginDate":"2023-10-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-20","modifiedBy":"SOKKERL","dateModified":"2023-10-20","deletedIndicator":"No"},{"value":"Rheumatologic Disorder","valueDescription":null,"ValueMeaning":{"publicId":"2971319","version":"1","preferredName":"Rheumatologic Disorder","longName":"2971319","preferredDefinition":"Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rheumatologic Disorder","conceptCode":"C27204","definition":"Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B198A4F-6835-7611-E040-BB89AD430A1F","latestVersionIndicator":"Yes","beginDate":"2009-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0780-0DFA-0449-E063-731AD00AE202","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"WAGR Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3211530","version":"1","preferredName":"Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome","longName":"3211530","preferredDefinition":"A very rare congenital condition involving the complex of Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WAGR Syndrome","conceptCode":"C3718","definition":"A very rare congenital condition involving the complex of Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0B69-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0780-0DFB-0449-E063-731AD00AE202","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Hemolytic Uremic Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2944885","version":"1","preferredName":"Hemolytic Uremic Syndrome","longName":"2944885","preferredDefinition":"A form of thrombotic microangiopathy with renal failure, hemolytic anemia, and severe thrombocytopenia and purpura","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemolytic Uremic Syndrome","conceptCode":"C75545","definition":"Acute kidney injury associated with microangiopathic hemolytic anemia and thrombocytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74464933-C5C9-B990-E040-BB89AD4340F0","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B719-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Thrombotic Thrombocytopenic Purpura","valueDescription":null,"ValueMeaning":{"publicId":"2944528","version":"1","preferredName":"Thrombotic Thrombocytopenic Purpura","longName":"2944528","preferredDefinition":"An acute or subacute syndrome characterized by the presence of microangiopathic hemolytic anemia, thrombocytopenic purpura, fever, renal abnormalities and neurologic abnormalities such as seizures, hemiplegia, and visual disturbances. Drugs and bacteria have been implicated as etiologic factors.  The introduction of plasma exchange has significantly lowered the mortality rate. If untreated, the mortality rate is high.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombotic Thrombocytopenic Purpura","conceptCode":"C78797","definition":"A coagulation disorder characterized by extensive formation of thrombi in small blood vessels throughout the body due to low levels of ADAMTS13 protein, and resulting in consumption of circulating platelets, which is characterized by thrombocytopenia, anemia, neurologic changes, and sometimes fever and renal dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743D5322-CCC1-677A-E040-BB89AD434340","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-23","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B71A-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Interstitial Pneumonia","valueDescription":null,"ValueMeaning":{"publicId":"6841447","version":"1","preferredName":"Interstitial Pneumonia","longName":"6841447","preferredDefinition":"Inflammation of interstitial lung tissue, usually associated with infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EEDB21B-5A19-25F6-E053-F662850A7B8E","latestVersionIndicator":"Yes","beginDate":"2019-07-30","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-07-30","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B71B-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Acute Respiratory Distress Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"5621721","version":"1","preferredName":"Interstitial pneumonitis or Acute Respiratory Distress Syndrome","longName":"5621721","preferredDefinition":"Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Respiratory Distress Syndrome","conceptCode":"C3353","definition":"Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-EDE0-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B71C-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","valueDescription":null,"ValueMeaning":{"publicId":"5611394","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","longName":"5611394","preferredDefinition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Neoplasm","conceptCode":"C38342","definition":"A usually slow-growing epithelial neoplasm with ductal differentiation that arises from the exocrine pancreas and grows mostly within the pancreatic ducts. Grossly, it is characterized by the presence of intraductal masses. Morphologically, there is proliferation of mucin-producing cells within the pancreatic ducts, intraductal accumulation of mucin, and a papillary growth pattern. It may be associated with the presence of an invasive carcinoma. It usually occurs in older patients. Signs and symptoms include epigastric pain, weight loss, jaundice, chronic pancreatitis, and diabetes mellitus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E429E5-2C76-4AE2-E053-F662850A4EE8","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ALEYR","dateCreated":"2016-12-30","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B71D-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Primary Immune Thrombocytopenia","valueDescription":null,"ValueMeaning":{"publicId":"2579903","version":"1","preferredName":"Idiopathic Thrombocytopenic Purpura","longName":"2579903","preferredDefinition":"Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Immune Thrombocytopenia","conceptCode":"C3446","definition":"Acquired thrombocytopenia of unknown cause, characterized by immune-mediated destruction of normal platelets. It affects both children and adults. It manifests with petechiae, purpura, and overt bleeding. Based upon the duration of the disease, it is classified as newly diagnosed (from diagnosis until 3 months), persistent (3-12 months), and chronic (lasting for more than 12 months).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-052C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B71E-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Kidney Disorder","valueDescription":null,"ValueMeaning":{"publicId":"2975595","version":"1","preferredName":"Renal Disorder","longName":"2975595","preferredDefinition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Disorder","conceptCode":"C3149","definition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0EDE-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B71F-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":null,"ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B720-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Lupus Erythematosus","valueDescription":null,"ValueMeaning":{"publicId":"3210816","version":"1","preferredName":"Lupus Erythematosus","longName":"3210816","preferredDefinition":"An autoimmune, connective tissue chronic inflammatory disorder affecting the skin, joints, kidneys, lungs, heart, and the peripheral blood cells. It is more commonly seen in women than men. Variants include discoid and systemic lupus erythematosus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lupus Erythematosus","conceptCode":"C27153","definition":"An autoimmune, connective tissue chronic inflammatory disorder affecting the skin, joints, kidneys, lungs, heart, and the peripheral blood cells. It is more commonly seen in women than men. Variants include discoid and systemic lupus erythematosus.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A4EC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B721-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Mycobacterium Avium Complex Lymphadenitis","valueDescription":null,"ValueMeaning":{"publicId":"2975593","version":"1","preferredName":"Mycobacterium Avium Intracellulare","longName":"2975593","preferredDefinition":"Lymph node infection by Mycobacterium avium or Mycobacterium intracellulare. It most often affects children and usually presents with cervical lymph node enlargement. It generally follows a benign clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mycobacterium Avium Complex Lymphadenitis","conceptCode":"C27314","definition":"Lymph node infection by Mycobacterium avium or Mycobacterium intracellulare. It most often affects children and usually presents with cervical lymph node enlargement. It generally follows a benign clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B1E3-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B722-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Neuroendocrine Neoplasm","valueDescription":null,"ValueMeaning":{"publicId":"3211298","version":"1","preferredName":"Neuroendocrine Neoplasm","longName":"3211298","preferredDefinition":"A benign or malignant neoplasm composed of cells of neuroendocrine origin.  Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Neoplasm","conceptCode":"C3809","definition":"An epithelial neoplasm with neuroendocrine differentiation. This category includes neuroendocrine tumors, neuroendocrine carcinomas, and paragangliomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EA11-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B723-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Organ Graft","valueDescription":null,"ValueMeaning":{"publicId":"14554888","version":"1","preferredName":"Organ Graft","longName":"14554888v1.00","preferredDefinition":"The transfer of an organ, or organ subpart, from one body to another.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organ Graft","conceptCode":"C122934","definition":"An organ that is transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"084E0EF0-B718-059A-E063-731AD00A5051","latestVersionIndicator":"Yes","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B724-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Pain","valueDescription":null,"ValueMeaning":{"publicId":"4614752","version":"1","preferredName":"Pain","longName":"4614752","preferredDefinition":"An unpleasant sensation associated with real or perceived physical or mental trauma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pain","conceptCode":"C3303","definition":"The sensation of discomfort, distress, or agony, resulting from the stimulation of specialized nerve endings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08EE1F25-CD30-F7EA-E050-BB89AD432750","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B725-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Peptic Ulcer","valueDescription":null,"ValueMeaning":{"publicId":"2573562","version":"1","preferredName":"Peptic Ulcer","longName":"2573562","preferredDefinition":"Ulcer that occurs in those portions of the alimentary tract which come into contact with gastric juice containing pepsin and acid. It occurs when the amount of acid and pepsin is sufficient to overcome the gastric mucosal barrier.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peptic Ulcer","conceptCode":"C3318","definition":"A mucosal erosion that occurs in the esophagus, stomach or duodenum. Symptoms can include abdominal pain, nausea and vomiting, and bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC67-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B726-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Peripheral Vascular Disorder","valueDescription":null,"ValueMeaning":{"publicId":"4395396","version":"1","preferredName":"Peripheral Vascular Disorder","longName":"4395396","preferredDefinition":"Any disorder affecting blood flow through the veins or arteries outside of the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peripheral Vascular Disorder","conceptCode":"C35136","definition":"Any disorder affecting blood flow through the veins or arteries outside of the heart.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB6B12D-7EE6-54C8-E040-BB89AD433F90","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B727-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Pregnancy","valueDescription":null,"ValueMeaning":{"publicId":"5621711","version":"1","preferredName":"Pregnancy","longName":"5621711","preferredDefinition":"The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pregnancy","conceptCode":"C25742","definition":"The state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-EBFE-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B728-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Renal Failure","valueDescription":null,"ValueMeaning":{"publicId":"5095719","version":"1","preferredName":"Renal Failure","longName":"5095719","preferredDefinition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2837D986-61CE-631F-E050-BB89AD4324FB","latestVersionIndicator":"Yes","beginDate":"2015-12-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-31","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E0EF0-B729-059A-E063-731AD00A5051","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Barrett Esophagus","valueDescription":null,"ValueMeaning":{"publicId":"3210773","version":"1","preferredName":"Barrett Esophagus","longName":"3210773","preferredDefinition":"Esophageal segment lined with columnar metaplastic epithelium which is flat or villiform.  Barrett's epithelium is characterized by two different types of cells: goblet cells and columnar cells.  The symptomatology of Barrett's esophagus is that of gastro-esophageal reflux.  It is the precursor of most esophageal adenocarcinomas.  (WHO, 2000) -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Barrett Esophagus","conceptCode":"C2891","definition":"Esophageal lesion lined with columnar metaplastic epithelium which is flat or villiform. Barrett epithelium is characterized by two different types of cells: goblet cells and columnar cells. The symptomatology of Barrett esophagus is that of gastro-esophageal reflux. It is the precursor of most esophageal adenocarcinomas.  (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9D5E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1635-2F40-06CD-E063-731AD00A50E4","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Beckwith-Wiedemann Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2967368","version":"1","preferredName":"Beckwith-Wiedemann Syndrome","longName":"2967368","preferredDefinition":"A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beckwith-Wiedemann Syndrome","conceptCode":"C34415","definition":"A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, rhabdomyosarcoma) and adrenal cortex carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-57DC-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1635-2F41-06CD-E063-731AD00A50E4","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Behcet Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2593579","version":"1","preferredName":"Behcet Syndrome","longName":"2593579","preferredDefinition":"Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS, THROMBOPHLEBITIS, gastrointestinal ulcerations, RETINAL VASCULITIS, and OPTIC ATROPHY may occur as well.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Behcet Syndrome","conceptCode":"C34416","definition":"A rare chronic inflammatory disorder of unknown etiology. It is characterized by the development of ulcers in the mouth and genital region and uveitis. Other signs and symptoms include arthritis, deep vein thrombosis and superficial thrombophlebitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28C01CF8-E883-093C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1635-2F42-06CD-E063-731AD00A50E4","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Cataract","valueDescription":null,"ValueMeaning":{"publicId":"2797325","version":"1","preferredName":"Cataract","longName":"2797325","preferredDefinition":"Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness.  Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Diagnostic Surgical Pathology, 3rd ed.) --2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cataract","conceptCode":"C26713","definition":"Partial or complete opacity of the crystalline lens of one or both eyes that decreases visual acuity and eventually results in blindness. Some cataracts appear in infancy or in childhood, but most develop in older individuals. (Sternberg Diagnostic Surgical Pathology, 3rd ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AD63DAD-D834-12B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-11-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E255-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Cryptogenic Cirrhosis","valueDescription":null,"ValueMeaning":{"publicId":"3210782","version":"1","preferredName":"Cryptogenic Cirrhosis","longName":"3210782","preferredDefinition":"Cirrhosis in which no causative agent can be identified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cryptogenic Cirrhosis","conceptCode":"C84411","definition":"Cirrhosis in which no causative agent can be identified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9ED2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E256-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Cerebrovascular Disorder","valueDescription":null,"ValueMeaning":{"publicId":"2970710","version":"1","preferredName":"Cerebrovascular Disorder","longName":"2970710","preferredDefinition":"A broad category of disorders characterized by impairment of blood flow in the arteries and veins which supply the brain. These include CEREBRAL INFARCTION; BRAIN ISCHEMIA; HYPOXIA, BRAIN; INTRACRANIAL EMBOLISM AND THROMBOSIS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; and VASCULITIS, CENTRAL NERVOUS SYSTEM. In common usage, the term cerebrovascular disorders is not limited to conditions that affect the cerebrum, but refers to vascular disorders of the entire brain including the DIENCEPHALON; BRAIN STEM; and CEREBELLUM.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebrovascular Disorder","conceptCode":"C2938","definition":"A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B03BA39-F9B5-A853-E040-BB89AD433913","latestVersionIndicator":"Yes","beginDate":"2009-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E257-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Colon Polyp","valueDescription":null,"ValueMeaning":{"publicId":"4827926","version":"1","preferredName":"Colon Polyp","longName":"4827926","preferredDefinition":"A polypoid lesion that arises from the colon and protrudes into the lumen.  This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Polyp","conceptCode":"C2954","definition":"A polypoid lesion that arises from the colon and protrudes into the lumen.  This group includes adenomatous polyps, serrated polyps, and hamartomatous polyps.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F37E-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E258-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Congestive Heart Failure","valueDescription":null,"ValueMeaning":{"publicId":"2565944","version":"1","preferredName":"Congestive heart failure","longName":"2565944","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E259-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Chronic Obstructive Pulmonary Disease","valueDescription":null,"ValueMeaning":{"publicId":"4395784","version":"1","preferredName":"Chronic Obstructive Pulmonary Disease","longName":"4395784","preferredDefinition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-DB13-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E25A-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Crohn Disease","valueDescription":null,"ValueMeaning":{"publicId":"6650859","version":"1","preferredName":"Crohn's Disease (CD)","longName":"6650859","preferredDefinition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Crohn Disease","conceptCode":"C2965","definition":"A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82473C0D-C3D5-1361-E053-F662850A0559","latestVersionIndicator":"Yes","beginDate":"2019-02-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-02-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E25B-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Thromboembolism","valueDescription":null,"ValueMeaning":{"publicId":"3024906","version":"1","preferredName":"Thromboembolism","longName":"3024906","preferredDefinition":"Occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thromboembolism","conceptCode":"C28195","definition":"Occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"81D8D5D4-EC75-FF30-E040-BB89AD436639","latestVersionIndicator":"Yes","beginDate":"2010-03-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-03-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E25C-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Deep Vein Thrombosis","valueDescription":null,"ValueMeaning":{"publicId":"5296770","version":"1","preferredName":"Deep Vein Thrombosis","longName":"5296770","preferredDefinition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deep Vein Thrombosis","conceptCode":"C49343","definition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3565D051-59F6-E09A-E050-BB89AD4359CB","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-16","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E25D-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Diabetes Mellitus","valueDescription":null,"ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1DDB-E25E-083E-E063-731AD00A2290","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Type 1 Diabetes Mellitus","valueDescription":null,"ValueMeaning":{"publicId":"5054471","version":"1","preferredName":"Type 1 Diabetes Mellitus","longName":"5054471","preferredDefinition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 1 Diabetes Mellitus","conceptCode":"C2986","definition":"A chronic condition characterized by minimal or absent production of insulin by the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6B65-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1EB1-55B6-085E-E063-731AD00A17BB","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Type 2 Diabetes Mellitus","valueDescription":null,"ValueMeaning":{"publicId":"2976115","version":"1","preferredName":"Type 2 Diabetes Mellitus","longName":"2976115","preferredDefinition":"A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type 2 Diabetes Mellitus","conceptCode":"C26747","definition":"A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C59A54D-BA0C-5B26-E040-BB89AD432407","latestVersionIndicator":"Yes","beginDate":"2010-01-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-01-04","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E1EB1-55B7-085E-E063-731AD00A17BB","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Pulmonary Embolism","valueDescription":null,"ValueMeaning":{"publicId":"4395768","version":"1","preferredName":"Pulmonary Embolism","longName":"4395768","preferredDefinition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Embolism","conceptCode":"C50713","definition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D8E1-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69A5-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Seizure Disorder","valueDescription":null,"ValueMeaning":{"publicId":"4827918","version":"1","preferredName":"Seizure Disorder","longName":"4827918","preferredDefinition":"A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure Disorder","conceptCode":"C3020","definition":"A brain disorder characterized by episodes of abnormally increased neuronal discharge resulting in transient episodes of sensory or motor neurological dysfunction, or psychic dysfunction. These episodes may or may not be associated with loss of consciousness or convulsions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F1BB-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69A6-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Gonadal Disorder","valueDescription":null,"ValueMeaning":{"publicId":"5621716","version":"1","preferredName":"Gonadal Disorder","longName":"5621716","preferredDefinition":"Disease of the ovaries and testes of any etiology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gonadal Disorder","conceptCode":"C26786","definition":"A non-neoplastic or neoplastic disorder that affects the testis or the ovary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-ECF5-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69A7-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Nevoid Basal Cell Carcinoma Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3210902","version":"1","preferredName":"Nevoid Basal Cell Carcinoma Syndrome","longName":"3210902","preferredDefinition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH gene.  It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida).  Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nevoid Basal Cell Carcinoma Syndrome","conceptCode":"C2892","definition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH and SUFU gene. It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida). Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B1D8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69A8-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Helicobacter Pylori Infection","valueDescription":null,"ValueMeaning":{"publicId":"6148978","version":"1","preferredName":"Helicobacter Pylori Infection","longName":"6148978","preferredDefinition":"A bacterial infection of the stomach, caused by Helicobacter pylori.  It is associated with the development of peptic ulcer and mucosa-associated lymphoid tissue lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Helicobacter Pylori Infection","conceptCode":"C39293","definition":"A bacterial infection of the stomach, caused by Helicobacter pylori.  It is associated with the development of peptic ulcer and mucosa-associated lymphoid tissue lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6853938B-5D6E-7948-E053-F662850A1496","latestVersionIndicator":"Yes","beginDate":"2018-03-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-26","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69A9-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Hashimoto Thyroiditis","valueDescription":null,"ValueMeaning":{"publicId":"5417296","version":"1","preferredName":"Hashimoto thyroiditis","longName":"5417296","preferredDefinition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hashimoto Thyroiditis","conceptCode":"C27191","definition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A49A30E-42AE-4645-E050-BB89AD432879","latestVersionIndicator":"Yes","beginDate":"2016-08-17","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-17","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69AA-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Heart Disorder","valueDescription":null,"ValueMeaning":{"publicId":"3181118","version":"1","preferredName":"Heart Disorder","longName":"3181118","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Disorder","conceptCode":"C3079","definition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"991CC1A7-5429-0D9B-E040-BB89AD4320EF","latestVersionIndicator":"Yes","beginDate":"2011-01-05","endDate":null,"createdBy":"LUY","dateCreated":"2011-01-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69AB-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Chronic Hepatitis","valueDescription":null,"ValueMeaning":{"publicId":"6423725","version":"1","preferredName":"Chronic Hepatitis","longName":"6423725","preferredDefinition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Hepatitis","conceptCode":"C82978","definition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-87E0-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69AC-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Hereditary Nonpolyposis Colorectal Cancer Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"14554889","version":"1","preferredName":"Hereditary Nonpolyposis Colorectal Cancer Syndrome","longName":"14554889v1.00","preferredDefinition":"An inherited syndrome characterized by the development of several cancers, particularly colon and rectal cancers.  It includes Lynch syndrome which is associated with germline mutations in DNA mismatch-repair genes and familial colorectal cancer type X which is characterized by the absence of germline mutations in DNA mismatch-repair genes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Nonpolyposis Colorectal Cancer Syndrome","conceptCode":"C120083","definition":"An inherited syndrome characterized by the development of several cancers, particularly colon and rectal cancers.  It includes Lynch syndrome which is associated with germline mutations in DNA mismatch-repair genes and familial colorectal cancer type X which is characterized by the absence of germline mutations in DNA mismatch-repair genes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"084E219C-69A3-0904-E063-731AD00AECE5","latestVersionIndicator":"Yes","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69AD-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Herpes Simplex Dermatitis","valueDescription":null,"ValueMeaning":{"publicId":"14554890","version":"1","preferredName":"Herpes Simplex Dermatitis","longName":"14554890v1.00","preferredDefinition":"Localized rash characterized by grouped vesicles or pustules on an erythematous base that is caused by herpes simplex virus infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Herpes Simplex Dermatitis","conceptCode":"C35620","definition":"Localized rash characterized by grouped vesicles or pustules on an erythematous base that is caused by herpes simplex virus infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"084E219C-69A4-0904-E063-731AD00AECE5","latestVersionIndicator":"Yes","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69AE-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Acquired Immunodeficiency Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"3105388","version":"1","preferredName":"Acquired Immunodeficiency Syndrome","longName":"3105388","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88262FC2-CEBC-A44E-E040-BB89AD435306","latestVersionIndicator":"Yes","beginDate":"2010-06-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E219C-69AF-0904-E063-731AD00AECE5","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Osteopenia","valueDescription":null,"ValueMeaning":{"publicId":"2857212","version":"1","preferredName":"Osteopenia","longName":"2857212","preferredDefinition":"Decreased calcification or density of bone tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteopenia","conceptCode":"C50910","definition":"Decreased calcification or density of bone tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"661EB49B-B2FE-7D2B-E040-BB89AD4340DC","latestVersionIndicator":"Yes","beginDate":"2009-03-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E23FF-B603-0973-E063-731AD00AF974","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Osteoporosis","valueDescription":null,"ValueMeaning":{"publicId":"2945846","version":"1","preferredName":"Osteoporosis","longName":"2945846","preferredDefinition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteoporosis","conceptCode":"C3298","definition":"A condition of reduced bone mass, with decreased cortical thickness and a decrease in the number and size of the trabeculae of cancellous bone (but normal chemical composition), resulting in increased fracture incidence. Osteoporosis is classified as primary (Type 1, postmenopausal osteoporosis; Type 2, age-associated osteoporosis; and idiopathic, which can affect juveniles, premenopausal women, and middle-aged men) and secondary osteoporosis (which results from an identifiable cause of bone mass loss).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74597246-1619-6D19-E040-BB89AD431E08","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E23FF-B604-0973-E063-731AD00AF974","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Pancreatitis","valueDescription":null,"ValueMeaning":{"publicId":"2946003","version":"1","preferredName":"Pancreatitis","longName":"2946003","preferredDefinition":"Inflammation of the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatitis","conceptCode":"C3306","definition":"Inflammation of the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-41F3-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E23FF-B605-0973-E063-731AD00AF974","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Biliary System Disorder","valueDescription":null,"ValueMeaning":{"publicId":"3210777","version":"1","preferredName":"Biliary Tract Disorder","longName":"3210777","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the intrahepatic or extrahepatic biliary tract. Examples of non-neoplastic disorders include infection and atresia. Examples of neoplastic disorders include adenoma and carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biliary System Disorder","conceptCode":"C2899","definition":"A non-neoplastic or neoplastic disorder that affects the intrahepatic or extrahepatic bile ducts or the gallbladder. Representative examples of non-neoplastic disorders include cholangitis and cholecystitis. Representative examples of neoplastic disorders include extrahepatic bile duct adenoma, intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9DF0-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E25DB-47C9-09A4-E063-731AD00A6FED","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Fracture","valueDescription":null,"ValueMeaning":{"publicId":"5621718","version":"1","preferredName":"Fracture","longName":"5621718","preferredDefinition":"A traumatic injury to the bone in which the continuity of the bone is broken.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fracture","conceptCode":"C3046","definition":"A traumatic injury to the bone in which the continuity of the bone is broken.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45AE87ED-ED50-6297-E053-F662850A80DB","latestVersionIndicator":"Yes","beginDate":"2017-01-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2017-01-09","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E25DB-47CA-09A4-E063-731AD00A6FED","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Calcium Channel Blocker","valueDescription":null,"ValueMeaning":{"publicId":"2970708","version":"1","preferredName":"Calcium Channel Blocker","longName":"2970708","preferredDefinition":"A class of drugs that act by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. Since they are inducers of vascular and other smooth muscle relaxation, they are used in the drug therapy of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calcium Channel Blocker","conceptCode":"C333","definition":"A pharmaceutical agent that inhibits the movement of calcium across through calcium channels in the cell membrane, preventing or decreasing the amount of calcium able to enter the cell. These drugs are used for their chronotropic, antihypertensive and vasodilatory effects.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B03BA39-F962-A853-E040-BB89AD433913","latestVersionIndicator":"Yes","beginDate":"2009-12-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-18","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E25DB-47CB-09A4-E063-731AD00A6FED","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"},{"value":"Malignant Neoplasm","valueDescription":null,"ValueMeaning":{"publicId":"2749852","version":"1","preferredName":"Malignant Neoplasm","longName":"2749852","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D47F93B-9A03-2D84-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-15","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"084E25DB-47CC-09A4-E063-731AD00A6FED","beginDate":"2023-10-22","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-10-22","modifiedBy":"SOKKERL","dateModified":"2023-10-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2737104","version":"1","preferredName":"Comorbidity Type","preferredDefinition":"The coexistence of two or more disease processes.:Type; a subdivision of a particular kind of thing.","longName":"C16457:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Comorbidity","conceptCode":"C16457","definition":"The coexistence of two or more disease processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"495A4F7C-90EB-4C68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-26","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-26","modifiedBy":"SBREXT","dateModified":"2008-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"05BC6FF1-57F7-52BF-E063-731AD00AD2A3","latestVersionIndicator":"Yes","beginDate":"2023-09-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-09-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594092","version":"1","longName":"Participant","context":"Pediatric Cancer"},{"publicId":"13596245","version":"1","longName":"Follow Up","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"comorbidity","type":"CCDI Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Comorbidity Type","url":null,"context":"Pediatric Cancer"}],"origin":"CCDI:Childhood Cancer Data Initiative","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"05BC7805-BC36-53DF-E063-731AD00A5C2E","latestVersionIndicator":"Yes","beginDate":"2023-09-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-09-19","modifiedBy":"COLBERTM","dateModified":"2023-10-17","changeDescription":null,"administrativeNotes":"10/17/23 Edited OC and property from Comorbidity Occurrence. mr; \r\n9/19/23-created it per the CCDI submission template.ls","unresolvedIssues":null,"deletedIndicator":"No"}}